France· FR:62344129
DOGMATIL 50 mg, gélule
A sulpiride product containing sulpiride, registered in France by NEURAXPHARM FRANCE, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Sulpiride is registered in 12 of 19 countries.
Countries holding a registration under ATC N05AL01 (sulpiride), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 7 of them publish a price we can compare per daily dose
Sulpiride · ATC N05AL01
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of sulpiride costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $1.00 in France to $3.83 in Switzerland — a ×3.8 gap.
- France: $1.00 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Sulpiride · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.83
- FR France$1.00
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULPIRIDE
- Manufacturer
- NEURAXPHARM FRANCE
- Country
- France (FR)
- ATC code
- N05AL01
- ATC class
- Sulpiride
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip133400930328972plaquette(s) thermoformée(s) PVC-aluminium de 30 gélule(s)EUR 2.32
- cip133400932668335plaquette(s) thermoformée(s) PVC-aluminium de 100 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
23 interactions on record for sulpiride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulpiride · interactions on record
23 records
23 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Sulpiride in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOGMATILneuraxpharm Arzneimittel GmbH, Langenfeld
- NetherlandsDogmatil 50, capsules 50 mgEuro Registratie Collectief B.V.
- SpainPSICOCEN 50 mg CAPSULASEspecialidades Farmaceuticas Centrum S.A.
- PolandSulpiryd TevaTeva Pharmaceuticals Polska Sp. z o.o.
- FinlandSupriumNeuraxpharm Sweden AB
- NorwayDogmatilNeuraxpharm
- BelgiumDogmatil 50 mgNeuraxpharm Belgium
- United KingdomDolmatil 200mg tabletsSanofi
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Dogmatil, Sulpirid Grindeks
- Belgium · Dogmatil, Sulpiride Eg
- Cyprus · Devodil, Sulpiren
- Czechia · Dogmatil, Prosulpin
- Germany · Dogmatil, Dogmatil Forte
- Estonia · Betamaks
- Spain · Dogmatil, Dogmatil Fuerte
- Finland · Suprium
- United Kingdom (Northern Ireland) · Sulpiride, Sulpiride Activase Pharmaceuticals
- Greece · Dogmatyl
- Croatia · Eglonyl, Eglonyl Forte
- Hungary · Depral
- Ireland · Dolmatil
- Italy · Dobren
- Lithuania · Eglonyl
- Luxembourg · Dogmatil, Sulpiride Eg
- Latvia · Betamaks
- Malta · Devodil, Sulpiride Grindeks
- Netherlands · Dogmatil
- Poland · Sulpiryd Hasco, Sulpiryd Teva
- Portugal · Dogmatil, Dogmatil Forte
- Romania · Eglonyl
- Slovenia · Eglonyl
- Slovakia · Betamaks, Sulpirid Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd41855b-101a-4b00-be58-47b852db99f6 GET /v1/drugs/cd41855b-101a-4b00-be58-47b852db99f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62344129",
"date_amm": "1987-07-01",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULPIRIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulpiride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.